deflazacort has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biggar, DW; Harris, VA; Silversides, CK; Webb, GD | 1 |
| Cengiz, B; Kuruoğlu, R; Sucak, G; Tan, E | 1 |
1 trial(s) available for deflazacort and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Cohort Studies; Echocardiography; Electrocardiography; Follow-Up Studies; Humans; Male; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Pregnenediones; Retrospective Studies; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
1 other study(ies) available for deflazacort and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Hypereosinophilic syndrome: progression of peripheral neuropathy despite controlled eosinophil levels.
Topics: Aged; Bone Marrow; Eosinophils; Fatigue; Female; Humans; Hypereosinophilic Syndrome; Immunosuppressive Agents; Leukocyte Count; Mental Disorders; Methylprednisolone; Muscle Weakness; Neural Conduction; Paraplegia; Peripheral Nervous System Diseases; Pregnenediones; Pulmonary Eosinophilia; Treatment Failure; Ventricular Dysfunction, Left | 1999 |